TICAM-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of TICAM-2 monoclonal antibodies for investigating TICAM-2's role in immune signaling pathways. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TICAM-2, also known as TRAM, functions as an adaptor protein in the Toll-like receptor (TLR) signaling pathway, particularly during viral infection responses. TICAM-2 plays a key role in activating downstream signaling cascades that trigger pro-inflammatory cytokine production. Research focused on TICAM-2 continues to reveal important aspects of innate immunity mechanisms. Understanding TICAM-2's functions provides valuable insights for developing new therapeutic approaches for immune-related disorders. Investigating TICAM-2 signaling pathways helps researchers better comprehend cellular responses to pathogens. Detailed analysis of TICAM-2's molecular interactions advances knowledge of immune system regulation. TICAM-2 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to immunology research and therapeutic development.